APA-Zitierstil (7. Ausg.)

Müller, M., Rösch, L., Najafi, S., Gatzweiler, C., Ridinger, J., Gerloff, X. F., . . . Oehme, I. (2021). Combining APR-246 and HDAC-inhibitors: A novel targeted treatment option for neuroblastoma. Cancers, 13(17), . https://doi.org/10.3390/cancers13174476

Chicago-Zitierstil (17. Ausg.)

Müller, Michael, et al. "Combining APR-246 and HDAC-inhibitors: A Novel Targeted Treatment Option for Neuroblastoma." Cancers 13, no. 17 (2021). https://doi.org/10.3390/cancers13174476.

MLA-Zitierstil (9. Ausg.)

Müller, Michael, et al. "Combining APR-246 and HDAC-inhibitors: A Novel Targeted Treatment Option for Neuroblastoma." Cancers, vol. 13, no. 17, 2021, https://doi.org/10.3390/cancers13174476.